Free Trial

BrightSpring Health Services (BTSG) Competitors

BrightSpring Health Services logo
$60.01 +0.79 (+1.34%)
As of 11:14 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BTSG vs. NTRA, GH, FMS, CELC, and HIMS

Should you buy BrightSpring Health Services stock or one of its competitors? MarketBeat compares BrightSpring Health Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BrightSpring Health Services include Natera (NTRA), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does BrightSpring Health Services compare to Natera?

BrightSpring Health Services (NASDAQ:BTSG) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, Natera had 6 more articles in the media than BrightSpring Health Services. MarketBeat recorded 24 mentions for Natera and 18 mentions for BrightSpring Health Services. Natera's average media sentiment score of 0.79 beat BrightSpring Health Services' score of 0.73 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
7 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Natera
11 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.9% of Natera shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 5.1% of Natera shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

BrightSpring Health Services has a net margin of 2.27% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 14.63% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Natera -9.05%-14.74%-10.27%

BrightSpring Health Services presently has a consensus target price of $58.53, suggesting a potential downside of 2.47%. Natera has a consensus target price of $256.12, suggesting a potential upside of 18.93%. Given Natera's higher probable upside, analysts plainly believe Natera is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11
Natera
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
2 Strong Buy rating(s)
2.81

BrightSpring Health Services has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$13.65B0.87$190.67M$1.4142.56
Natera$2.31B13.37-$208.16M-$1.63N/A

Summary

BrightSpring Health Services beats Natera on 10 of the 16 factors compared between the two stocks.

How does BrightSpring Health Services compare to Guardant Health?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

BrightSpring Health Services currently has a consensus price target of $58.53, suggesting a potential downside of 2.47%. Guardant Health has a consensus price target of $139.80, suggesting a potential upside of 12.15%. Given Guardant Health's higher probable upside, analysts clearly believe Guardant Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.95

In the previous week, BrightSpring Health Services had 1 more articles in the media than Guardant Health. MarketBeat recorded 18 mentions for BrightSpring Health Services and 17 mentions for Guardant Health. BrightSpring Health Services' average media sentiment score of 0.73 beat Guardant Health's score of 0.45 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
7 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Guardant Health -40.10%N/A -26.42%

92.6% of Guardant Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$13.65B0.87$190.67M$1.4142.56
Guardant Health$982.02M16.83-$416.28M-$3.39N/A

BrightSpring Health Services has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market.

Summary

BrightSpring Health Services beats Guardant Health on 12 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, BrightSpring Health Services had 16 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 18 mentions for BrightSpring Health Services and 2 mentions for Fresenius Medical Care AG & Co. KGaA. BrightSpring Health Services' average media sentiment score of 0.73 beat Fresenius Medical Care AG & Co. KGaA's score of 0.71 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
7 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to BrightSpring Health Services' net margin of 2.27%. BrightSpring Health Services' return on equity of 14.63% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
BrightSpring Health Services 2.27%14.63%4.41%

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $28.00, suggesting a potential upside of 25.23%. BrightSpring Health Services has a consensus target price of $58.53, suggesting a potential downside of 2.47%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, research analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.54$1.11B$1.9011.77
BrightSpring Health Services$13.65B0.87$190.67M$1.4142.56

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 11 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Celcuity?

Celcuity (NASDAQ:CELC) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Celcuity had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Celcuity and 18 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.73 beat Celcuity's score of -0.09 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
7 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
7 Very Negative mention(s)
Neutral
BrightSpring Health Services
7 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -244.61% -50.22%
BrightSpring Health Services 2.27%14.63%4.41%

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$177.04M-$3.90N/A
BrightSpring Health Services$13.65B0.87$190.67M$1.4142.56

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

Celcuity presently has a consensus price target of $152.09, indicating a potential upside of 64.23%. BrightSpring Health Services has a consensus price target of $58.53, indicating a potential downside of 2.47%. Given Celcuity's higher probable upside, equities analysts plainly believe Celcuity is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

Summary

BrightSpring Health Services beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does BrightSpring Health Services compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, BrightSpring Health Services had 1 more articles in the media than Hims & Hers Health. MarketBeat recorded 18 mentions for BrightSpring Health Services and 17 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.92 beat BrightSpring Health Services' score of 0.73 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
10 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
7 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.74$128.37M-$0.09N/A
BrightSpring Health Services$13.65B0.87$190.67M$1.4142.56

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

BrightSpring Health Services has a net margin of 2.27% compared to Hims & Hers Health's net margin of -0.56%. BrightSpring Health Services' return on equity of 14.63% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
BrightSpring Health Services 2.27%14.63%4.41%

Hims & Hers Health currently has a consensus target price of $28.70, indicating a potential upside of 3.38%. BrightSpring Health Services has a consensus target price of $58.53, indicating a potential downside of 2.47%. Given Hims & Hers Health's higher possible upside, equities research analysts clearly believe Hims & Hers Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

Summary

BrightSpring Health Services beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

Get BrightSpring Health Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTSG vs. The Competition

MetricBrightSpring Health ServicesMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$11.85B$8.80B$6.46B$11.95B
Dividend YieldN/A1.76%2.67%5.58%
P/E Ratio42.6123.5423.9423.78
Price / Sales0.8726.14531.66117.30
Price / Cash26.1212.8126.9937.25
Price / Book5.775.3210.556.76
Net Income$190.67M$177.20M$3.56B$337.14M
7 Day Performance1.13%-0.39%-0.93%-1.75%
1 Month Performance9.45%5.97%1.58%2.32%
1 Year Performance151.52%3.35%20.99%25.63%

BrightSpring Health Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTSG
BrightSpring Health Services
4.0116 of 5 stars
$60.01
+1.3%
$58.53
-2.5%
+145.6%$11.85B$13.65B42.6123,500
NTRA
Natera
4.1329 of 5 stars
$213.11
-2.6%
$256.81
+20.5%
+30.4%$31.99B$2.31BN/A6,140
GH
Guardant Health
2.376 of 5 stars
$128.64
-0.4%
$136.37
+6.0%
+159.9%$17.20B$1.08BN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
4.8521 of 5 stars
$20.61
-2.1%
$28.00
+35.9%
-23.6%$11.65B$19.36B11.031,488
CELC
Celcuity
3.0534 of 5 stars
$92.98
-24.4%
$150.27
+61.6%
+570.0%$6.48BN/AN/A40

Related Companies and Tools


This page (NASDAQ:BTSG) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners